Skip to main content
DCI logo

DCI · DONALDSON Co INC

Track DCI — free
$86.70 -0.29 (-0.33%) At close · Nov 13
Market Cap
$10.05B
Shares
115.91M
Volume · Nov 13 350.12K Avg daily vol (3M) 632.44K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$86.70 Open$87.41 Day$86.01–87.60 52W close$81.55–110.57 Avg vol 30d576K Short int3.3M · 2.9% of shares · 6.4d Short vol50% Last earningsAug 26, 2026 DataJan 2020–Nov 2026 Filing10-K · Sep 25

Up next

Dec 2, 2026 Scheduled · in 2 wks

Latest documents

2026
Oct 29
Current report 8-K Events of Oct 27
Plans $250 million initial senior unsecured notes offering

Donaldson Company entered an agreement to issue up to $1,500,000,000 of senior unsecured notes, with an initial $250 million series expected on January 12, 2027.

Entered into a material agreement, New debt or off-balance-sheet obligation Read from the first part of this long document
4 source passages
On October 27, 2026, Donaldson Company, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with a group of institutional investors (the “Purchasers”). Pursuant to the Note Purchase Agreement, the Company may issue up to $1,500,000,000 aggregate principal amount of senior unsecured notes from time to time in one or more series. Subject to the satisfaction of certain closing conditions, the Company will issue and sell to the Purchasers, in a private placement transaction, $250 million aggregate principal amount of an initial series of senior unsecured notes consisting of (i) $125,000,000 in aggregate principal amount of its 5.93% Series 2026-A, Tranche 1 senior notes due January 12, 2032 (the “Series 2026-A, Tranche 1 Notes”), (ii) $75,000,000 in aggregate principal amount of its 6.10% Series 2026-A, Tranche 2 senior notes due January 12, 2034 (the “Series 2026-A, Tranche 2 Notes”), and (iii) $50,000,000 in aggregate principal amount of its 6.23% Series 2026-A, Tranche 3 senior notes due January 12, 2037 (the “Series 2026-A, Tranche 3 Notes” and, together with the Series 2026-A, Tranche 1 Notes and the Series 2026-A, Tranche 2 Notes, the “Series 2026-A Notes”). The Series 2026-A Notes are expected to be issued on January 12, 2027. Open the document at this passage
Oct 6
Proxy statement DEF 14A
Proxy statement

Donaldson Company, Inc. recommends electing Tod E. Carpenter, Pilar Cruz, Richard B. Lewis and Simon A. Meester at its November 20, 2026 annual meeting, alongside advisory executive-compensation approval and ratification of PricewaterhouseCoopers LLP for the fiscal year ending July 31, 2027.

Read from the first part of this long document
Sep 25
Annual report 10-K FY2026, ended Jul 31
Annual report for FY2026

Donaldson Company, Inc. reported year ended July 31, 2026 net sales up $194.7 million, or 5.3%, net earnings of $453.8 million, up $86.8 million, or 23.7%, and diluted EPS of $3.85; increased debt funded the Facet acquisition.

Revenue $3.89B ▲ 5.3% Net income $453.8M ▲ 23.7% Diluted EPS $3.85 ▲ 26.2%
Read from the MD&A section
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.89B
Trailing 12 months
Net income (TTM)
$453.80M
Trailing 12 months
Revenue growth YoY
+8.0%
Year over year
Operating margin
15.4%
Trailing 12 months
P / E (TTM)
22.5
Trailing earnings · reciprocal yield 4.4%
FCF yield
4.2%
TTM · current market cap
Return on invested capital
16.4%
Trailing 12 months
Net cash
−$1.07B
Latest balance sheet
Dividend yield
1.4%
Trailing 12 months
Shares change YoY
-1.8%
Year over year · fewer shares
Price change (1Y)
+0.1%
Trailing year
Short interest
2.9%
Latest settlement · 6.4 days to cover
View all 125 metrics

AI Brief

Q4 FY26 earnings call · Aug 26, 2026
Q4 FY26

TL;DR. Donaldson reported record fiscal 2026 results with $3.9B sales (+5.3%) and adjusted EPS of $3.98 (+8.2%), and issued fiscal 2027 guidance for record sales of over $4.1B (+7.5% at midpoint) and EPS of $4.22–$4.38 inclusive of ~$0.12 FACET dilution.

Bullish
  • + Q4 industrial pre-tax margin improved 300 bps sequentially, with margins expected to normalize in 2H fiscal 2027
  • + FY27 guidance projects operating margin expansion of ~90 bps to 16.9% at midpoint, driven by gross margin expansion
  • + Mobile Solutions Q4 pre-tax margin reached a record 21.3%, up 220 bps YoY
Bearish
  • − Industrial Solutions Q4 pre-tax margin was 16.4%, down 450 bps YoY, pressured by FACET run-rate expenses and power generation production shifts
  • − Power generation facility in Mexico continues to pressure margins with ~40 bps gross margin headwind in Q4
  • − Industrial Filtration Solutions Q4 sales declined 2.0% YoY due to weaker dust collection new equipment volumes
  • − Fiscal 2027 interest expense is expected to rise to $55–$60M vs $36M prior year due to FACET-related debt
  • − Fiscal 2027 EPS guidance includes approximately $0.12 of dilution from the FACET acquisition

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −4%
below
Price vs 50-day avg −0%
below
RSI (14) 51
neutral
MACD trend Positive
52-week position 18%
mid-range
Momentum
relative strength
Neutral
1-month return −1%
trailing
6-month return +2%
trailing
YTD return −2%
this year
Relative strength +2%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $87 › 200d $90 — 200d above 50d
Institutional flow Accumulating
577 of 636 funds reported for Sep 30 · net +54.9K sh shares · +52 new
Insider flow Distributing
Net -$3.2M over 90 days · 100% sells
Short interest Rising
2.88% of shares out · ▲ +1.9% MoM · 6.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
636 holders — near 3-yr high, broad support
Squeeze score 55
elevated · 0–100
Fundamentals
Strong
Revenue growth +4%
Y/Y
Gross margin 47%
expanding
EPS growth +26%
Y/Y
Free cash flow $426.3M
Valuation P/E 22.5
below peers
Balance sheet $1.1B
net debt
Quant / Vol
risk profile
Moderate
Volatility 27%
annualized · 1-yr
Max drawdown −26%
past year
ATR 2.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 6
Latest guidance · from the Earnings Call filed Aug 26, 2026
fiscal 2027
Total sales growth Initiated 5.5% – 9.5%
Operating margin Initiated 16.6% – 17.2%
Sales growth in mobile solutions Initiated 2% – 6%
Sales growth in life sciences Initiated 7% – 11%
Aerospace and defense sales growth Initiated at least 50%
Capital expenditures Initiated $70M – $90M
Cash conversion Initiated 95% – 105%
full year
EPS guidance Initiated $4.22 – $4.38
prior FY $3.85 midpoint +11.7% Y/Y
Fiscal 27
Interest expense Initiated $55M – $60M
fiscal 27
Mobile solutions sales growth Initiated 2% – 6%
Life sciences sales growth Initiated 7% – 11%
second half of the year
Share of total sales in second half Initiated 52%
Share of total operating profit in second half Initiated 57%
Prior guidance period ended · from the Earnings Call filed Jun 2, 2026
Adjusted EPS excluding FACET · full year fiscal 2026 $3.94 – $4.01
Capital expenditures · full year fiscal 2026 $60M – $75M
Cash conversion · full year fiscal 2026 85% – 95%
Sales · fourth quarter $25M – $30M
Organic operating margin · full year 15.8% – 16.2%
Guided vs delivered · last 6 settled
Sales fiscal 2026
guided $3.8B
$3.89B Beat +2.3%
Earnings per share fiscal 2026
guided $3.93 – $4.01
$3.85 Miss −3.0%
Full-year EPS full year
guided $3.33 – $3.39
$3.38 In line
GAAP EPS Fiscal 2023 full-year
guided $2.90 – $2.96
$2.90 In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−4% Neutral
Price vs 50-day avg
−0% Neutral
RSI (14)
51 Neutral
MACD trend
Positive Bullish
52-week position
18% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $87 › 200d $90 — 200d above 50d
Institutional flow Accumulating
577 of 636 funds reported for Sep 30 · net +54.9K sh shares · +52 new
Insider flow Distributing
Net -$3.2M over 90 days · 100% sells
Short interest Rising
2.88% of shares out · ▲ +1.9% MoM · 6.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
636 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $82 Now $87 · 18% Range high $111
vs 200-day avg -4% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted diluted EPS non-GAAP $3.98 Twelve Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Diluted EPS $3.85
+$0 Impairment of intangible assets
+$0.13 Restructuring and other charges
-$0.06 Gain on the sale of fixed assets
+$0.06 Business development charges
= Adjusted diluted EPS $3.98
Adjusted EBITDA non-GAAP $748.8M Twelve Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Adjusted net earnings 469.7M
+137.1M Adjusted income taxes
+36M Interest expense
+106M Depreciation and amortization
= Adjusted EBITDA 748.8M
Adjusted gross margin non-GAAP 36.7% Q4 FY2026 —
Adjusted net earnings non-GAAP $469.7M Twelve Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net earnings 453.8M
+0M Impairment of intangible assets, net tax
+15.9M Restructuring and other charges, net tax
-7M Gain on the sale of fixed assets, net tax
+7M Business development charges, net tax
= Adjusted net earnings 469.7M
Adjusted operating income non-GAAP $621M Twelve Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Operating income 599.9M
+0M Impairment of intangible assets
+21.1M Restructuring and other charges
-9.3M Gain on the sale of fixed assets
+9.3M Business development charges
= Adjusted operating income 621M
Adjusted operating margin non-GAAP 17.5% Q4 FY2026 —
Dividends paid $141.2M Full Year Fiscal 2026 —
EBITDA $727.8M Twelve Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net earnings 453.8M
+132M Income taxes
+36M Interest expense
+106M Depreciation and amortization
= EBITDA 727.8M
Free cash flow non-GAAP $426.5M Twelve Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net cash provided by operating activities 493.7M
-67.2M Net capital expenditures
= Free cash flow 426.5M
Shares repurchased $108.5M Full Year Fiscal 2026 —
Aerospace and Defense 44.6M the three months ended April 30, 2026 filing —
Aftermarket 497.6M the three months ended April 30, 2026 filing —
Industrial Filtration Solutions (IFS) 237.1M the three months ended April 30, 2026 filing —
Life Sciences segment earnings before income taxes % of net sales 8.1% the three months ended April 30, 2026 filing —
Mobile Solutions segment earnings before income taxes % of net sales 20.2% the three months ended April 30, 2026 filing —
Off-Road 104M the three months ended April 30, 2026 filing —
On-Road 28.3M the three months ended April 30, 2026 filing —
Remaining authorization to repurchase shares 4.5M the three months ended April 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Industrial Machinery — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DCI
DONALDSON Co INC
this stock
$10.05B -2.2% +4.0% 22.5 2.9%
GEV
GE Vernova Inc.
$212.57B +22.9% +9.0% 21.1 2.8%
ETN
Eaton Corp plc
$137.13B +10.8% +10.3% 35.3 1.8%
SMERY
Siemens Energy AG
$123.80B — — — 0.0%
PH
Parker-Hannifin Corp
$120.51B +8.7% +18.9% 32.8 1.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
656
% held
90.8%
Reported
577 of 636
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
491
View
Short & Settlement
Short Interest Rising
Shares short
3.3M
Days to cover
6.4d
Change
+63.8K sh
View
Short Volume
Short vol %
50%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
659
Value
$57.4K
As of
Oct 9, 2026
View
Off-Exchange
Off-exchange %
40.0%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$3.2M
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Lois Frankel
Amount
$1.0K–$15.0K
Traded
Jan 11, 2022
View
Financials
Financials
Revenue (FY)
$2.8B
Net income (FY)
$453.8M
EPS diluted
$3.85
View
Buybacks
Authorized
shares 13.0M
Remaining
shares 4.5M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 29, 2026
This year
16

Donaldson Company entered an agreement to issue up to $1,500,000,000 of senior unsecured notes, with an initial $250 million series expected on January 12, 2027.

View
Proposed Sales
Value
$2.9M
Shares
32.0K
Filed
Sep 4, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 2, 2026
Last webcast
Sep 15, 2026
View
Investor Relations
Latest news
Donaldson Company to Present at t…
Published
Nov 6, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
DCI +2.8% -1.4% +2.3% +4.5% -2.2%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +0.2% -0.3% +1.8% +4.7% -12.8%

Capital returns

Latest dividend
$0.32 / share · ex Aug 17, 2026
Raised 6.7%
Paid (TTM)
$1.24 / share · 4 payouts
Dividend yield (TTM, derived)
1.43%
Full dividend history
Buyback program · as of Jul 31, 2026
Authorized
shares 13.00M
Spent (derived)
shares 8.50M
Remaining
shares 4.50M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 29644 CUSIP 257651109 13F (30d) 539 filings 484 filers Visit website Investor relations